SERA · Sera Prognostics, Inc. · Webcasts, Transcripts & Audio
$2.03
-0.02 (-0.98%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$80.87M
Shares
39.45M
Volume · Oct 28
259
Avg daily vol (3M)
23.3K
Sera Prognostics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Sera Prognostics, Inc. (SERA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-12
Sera Prognostics, Inc. (SERA) Q2 2026 Earnings Call Transcript
Confident tone
Payer engagement and commercialization pipeline
Illinois Medicaid legislation and reimbursement milestone
Clinical evidence and PRIME study publications
Revenue
$30,000
▲ 76.5% YoY Diluted EPS
$-0.18
Gross margin
-66.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
Sera Prognostics, Inc. (SERA) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
Sera Prognostics, Inc. (SERA) Q1 2026 Earnings Call Transcript
Positive tone
Payer Engagement and Reimbursement
Awareness and Media Outreach
Commercial Partnerships / Provider Programs
Revenue
$14,000
▼ 63.2% YoY Diluted EPS
$-0.17
Gross margin
-200.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-18
Sera Prognostics, Inc. (SERA) Q4 2025 Earnings Call Transcript
Confident tone
PRIME study publication and clinical evidence
Partner programs and state expansion
Commercial execution and sales force build-out
Revenue
$10,000*
▼ 58.3% YoY Gross margin
-320.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Sera Prognostics, Inc. (SERA) Q3 2025 Earnings Call Transcript
Positive tone
PRIME Study Publication
PreTRM Test Adoption
Medicaid and Payer Coverage
Revenue
$16,000
▼ 44.8% YoY Diluted EPS
$-0.16
Gross margin
-156.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Sera Prognostics, Inc. (SERA) Q2 2025 Earnings Call Transcript
Confident tone
PRIME Study Publication
European Expansion Plans
Professional Society and ACOG Engagement
Revenue
$17,000
▼ 29.2% YoY Diluted EPS
$-0.16
Gross margin
-141.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Sera Prognostics, Inc. (SERA) Q1 2025 Earnings Call Transcript
Positive tone
Medical society guidelines (ACOG/SMFM)
PRIME study results and health economics
Sales force expansion and physician awareness
Revenue
$38,000
Diluted EPS
$-0.20
Gross margin
-5.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-19
Sera Prognostics, Inc. (SERA) Q4 2024 Earnings Call Transcript
Positive tone
PRIME study results
Evidence portfolio and publications
Payer engagement and reimbursement
Revenue
$24,000*
▼ 41.5% YoY Gross margin
-33.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Sera Prognostics, Inc. (SERA) Q3 2024 Earnings Call Transcript
Confident tone
PRIME clinical trial and publication
Payer coverage and economic evidence
Commercial execution and test adoption
Revenue
$29,000
▼ 31% YoY Diluted EPS
$-0.24
Gross margin
55.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call
Revenue
$24,000
▼ 80.5% YoY Diluted EPS
$-0.25
Gross margin
16.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Sera Prognostics, Inc. (SERA) Q1 2024 Earnings Call Transcript
Positive tone
Clinical study publications (AVERT and PRIME)
Cash management and operating expense discipline
Health equity and awareness campaigns
Revenue
$0
▼ 100% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-20
Sera Prognostics, Inc. (SERA) Q4 2023 Earnings Call Transcript
Positive tone
PRIME study and publication
Guideline-setting bodies
PreTRM Test economics and value proposition
Revenue
$41,000*
▼ 36.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Sera Prognostics, Inc. (SERA) Q3 2023 Earnings Call Transcript
Revenue
$42,000
▼ 51.7% YoY Diluted EPS
$-0.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Sera Prognostics, Inc. (SERA) Q2 2023 Earnings Call Transcript
Revenue
$123,000
▲ 57.7% YoY Diluted EPS
$-0.34
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Sera Prognostics, Inc. (SERA) Q1 2023 Earnings Call Transcript
Revenue
$100,000
▲ 163.2% YoY Diluted EPS
$-0.34
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-22
Sera Prognostics, Inc. (SERA) Q4 2022 Earnings Call Transcript
Revenue
$65,000*
▲ 150% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Sera Prognostics, Inc. (SERA) Q3 2022 Earnings Call Transcript
Revenue
$87,000
▲ 278.3% YoY Diluted EPS
$-0.35
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Call Transcript
Revenue
$78,000
▲ 290% YoY Diluted EPS
$-0.37
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Sera Prognostics, Inc. (SERA) Q1 2022 Earnings Call Transcript
Revenue
$38,000
▲ 192.3% YoY Diluted EPS
$-0.40
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-29
Sera Prognostics, Inc. (SERA) Q4 2021 Earnings Call Transcript
Revenue
$26,000*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Sera Prognostics, Inc. (SERA) Q3 2021 Earnings Call
Revenue
$23,000
▲ 360% YoY Diluted EPS
$-0.39
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Showing 1–21 of 21 webcasts
Key facts
CIK
1534969
CUSIP
81749D107
13F (30d)
11 filings
11 filers
Visit website
Investor relations